Australia markets close in 5 hours 18 minutes
  • ALL ORDS

    7,241.20
    +10.20 (+0.14%)
     
  • ASX 200

    6,981.10
    +4.20 (+0.06%)
     
  • AUD/USD

    0.7644
    -0.0003 (-0.04%)
     
  • OIL

    60.50
    +0.32 (+0.53%)
     
  • GOLD

    1,746.10
    -1.50 (-0.09%)
     
  • BTC-AUD

    82,888.63
    +3,960.88 (+5.02%)
     
  • CMC Crypto 200

    1,360.64
    +66.65 (+5.15%)
     
  • AUD/EUR

    0.6391
    -0.0004 (-0.07%)
     
  • AUD/NZD

    1.0819
    -0.0010 (-0.09%)
     
  • NZX 50

    12,675.35
    +18.95 (+0.15%)
     
  • NASDAQ

    13,986.49
    +167.09 (+1.21%)
     
  • FTSE

    6,890.49
    +1.37 (+0.02%)
     
  • Dow Jones

    33,677.27
    -68.13 (-0.20%)
     
  • DAX

    15,234.36
    +19.36 (+0.13%)
     
  • Hang Seng

    28,497.25
    +43.95 (+0.15%)
     
  • NIKKEI 225

    29,621.91
    +83.21 (+0.28%)
     

Scientist Entrepreneurs - Scaling Breakout Engineering Biology Companies

TC Video
·1-min read

Biology as technology will re-invent trillion dollar industries and enhance human and planetary evolution. In this session, two early-stage investors and company builders, Arvind Gupta and Ursheet Parikh, will be in conversation with a leading author and seed investor Po Bronson, Managing Director of IndieBio. They will share their playbook on scaling start-ups touching upon three seminal areas which influence trajectory – fundraising, hiring, and product design. Their insights will draw on their experience with companies including ingredients-as-service leader Geltor which raised a $91 million Series B in 2020, CRISPR platform Mammoth Biosciences whose dream team includes co-founder Nobel Laureate Jennifer Doudna, and Endpoint Health, started by the founding team of GeneWEAVE (acquired by Roche) and former YC Bio Partner Diego Rey, which is designing a new class of therapeutic products that focus on hospital conditions that kill as many people as cancer.